Judy Lieberman, MD, PhD

Articles by Judy Lieberman, MD, PhD

Judy Lieberman, MD, PhD, on the Changing Field of RNA-Based Treatments

March 21st 2024

The endowed chair in cellular and molecular medicine at Boston Children’s Hospital discussed the rapid advancements in RNA-based treatments in the past 2 decades and potential advancements that remain on the horizon.

Judy Lieberman, MD, PhD, on Developing siRNA Therapies That Target Specific Cell Types

ByJudy Lieberman, MD, PhD

March 2nd 2024

The endowed chair in cellular and molecular medicine at Boston Children’s Hospital discussed past, present, and potential future applications of siRNA in the treatment of various diseases.

Judy Lieberman, MD, PhD

Articles by Judy Lieberman, MD, PhD

Judy Lieberman, MD, PhD, on the Changing Field of RNA-Based Treatments

Judy Lieberman, MD, PhD, on Developing siRNA Therapies That Target Specific Cell Types

Latest Updated Articles

Trending on CGTlive®

Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation

Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025

Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial

FDA Picks Abeona’s XLRS Gene Therapy ABO-503 for RDEA Pilot Program

BLA for Rocket’s LAD-I Gene Therapy Under Review by FDA Again